CA Patent

CA2481876A1 — Inhalation kit comprising inhalable powder of tiotropium

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2003-10-16 · 23y expired

What this patent protects

The invention relates to a method for the administration of powdered preparations containing tiotropium via inhalation.

USPTO Abstract

The invention relates to a method for the administration of powdered preparations containing tiotropium via inhalation.

Drugs covered by this patent

olodaterol-hydrochloride (OLODATEROL HYDROCHLORIDE)

Patent Metadata

Patent number: CA2481876A1
Jurisdiction: CA
Classification: —
Expires: 2003-10-16
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.